Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$6.75 - $12.89 $87,142 - $166,409
-12,910 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$5.8 - $18.56 $74,878 - $239,609
12,910 New
12,910 $98,000
Q4 2018

Feb 12, 2019

SELL
$16.21 - $24.06 $199,836 - $296,611
-12,328 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$8.0 - $22.11 $8,576 - $23,701
-1,072 Reduced 8.0%
12,328 $272,000
Q2 2018

Aug 08, 2018

BUY
$7.79 - $9.84 $104,386 - $131,856
13,400 New
13,400 $108,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $250M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.